The Numbers Are Sobering: Patients with HH face a 20-fold increased risk of liver cancer, with an absolute risk of 6% among men and 1.5% among women at 10 years of follow-up A comparative study found that patients with HH had a relative risk of 1.8 for developing hepatocellular carcinoma and 1.8 for non-hepatic cancers compared to matched controls with non-iron-related chronic liver disease The incidence of hepatocellular carcinoma in individuals with hereditary hemochromatosis is 200 times greater than in the general population But the cancer risk extends beyond the liver
Another example is systemic lupus erythematosus (SLE), a systemic autoimmune disease characterized by the production of autoantibodies against nuclear antigens
Pinti MV, Fink GK, Hathaway QA, Durr AJ, Kunovac A, Hollander JM
10 mL vial Bacteriostatic sodium chloride for injection Contains preservative Sterile diluent solution Used for reconstitution or dilution of compatible medications Suitable for multiple-dose vial use when handled properly Manufactured by Pfizer Intended for professional or directed medical use Practical for clinics, pharmacies, and healthcare settings Provides a sterile diluent option for compatible injectable medications Preservative-containing formula supports repeated vial access within approved use limits Convenient 10 mL size for medication preparation Helps support accurate medication mixing when used as directed Useful for healthcare professionals, clinics, and medication preparation workflows Pfizer brand supports trusted pharmaceutical sourcing Practical for settings requiring bacteriostatic diluent supply Ideal for use as a diluent for compatible medications that require sterile sodium chloride solution for injection preparation, reconstitution, or dilution as directed by a healthcare professional
Human cardiovascular adjustments to exercise and thermal stress
